These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34372554)

  • 1. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
    Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
    Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of bacteriophages against E.coli urinary tract infection and evaluating their anti-biofilm activity and antibiotic synergy.
    Devi B A; K V L; Sugumar S
    Microb Pathog; 2024 Aug; 193():106789. PubMed ID: 38972365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
    Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of auto-agglutinating and non-typeable uropathogenic Escherichia coli strains.
    Hernández-Chiñas U; Pérez-Ramos A; Belmont-Monroy L; Chávez-Berrocal ME; González-Villalobos E; Navarro-Ocaña A; Eslava CA; Molina-Lopez J
    J Infect Dev Ctries; 2019 Jun; 13(6):465-472. PubMed ID: 32058980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterisation of new phage targeting uropathogenic Escherichia coli.
    Asgharzadeh Kangachar S; Logel DY; Trofimova E; Zhu HX; Zaugg J; Schembri MA; Weynberg KD; Jaschke PR
    Virology; 2024 Sep; 597():110148. PubMed ID: 38941748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
    Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
    Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
    Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
    Malik S; Nehra K; Mann A; Jagdish R; Rana JS
    Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
    Zalewska-Piątek BM; Piątek RJ
    Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
    Zhao F; Yang H; Bi D; Khaledi A; Qiao M
    Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.